|
Market Closed -
OTC Markets
15:53:58 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 7.618 USD | +5.08% |
|
+0.05% | +23.85% |
EPS & Dividend: Interpace Biosciences, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -36.61 | -18.09 | -25.91 | 0.8948 | 1.972 | 4.426 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 15.700 | 37.350 | 5.200 | 5.400 | 13.488 | 6.151 |
| Nbr of stocks (in thousands) | 808 | 835 | 853 | 869 | 880 | 886 |
| Announcement Date | 4/1/21 | 3/31/22 | 3/27/23 | 4/1/24 | 3/31/25 | 3/30/26 |
1USD in Million2USD
Estimates
Past dividends: Interpace Biosciences, Inc.
| 2026-08-27 | Significant Split/Dividend | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -238.02x | 24.29x | 15.82x | |
| 0.87% | 0.88% | 24.05x | 3.03x | 2.19x | |
| 5.36% | 5.34% | 16.34x | 1.13x | 1.28x | |
| - | - | 1065.86x | - | - | |
| 0.96% | 1.04% | 52.23x | 11.3x | 9.63x | |
| - | - | -25.73x | - | - | |
| -.--% | -.--% | -60.45x | - | - | |
| 5.34% | 6.49% | 14.25x | 1.96x | 1.45x | |
| 1.45% | 2.17% | 30.99x | 1.79x | 1.64x | |
| Average | 2% | 2.27% | 97.72x | 7.25x | 5.34x | |
| Weighted average by Cap. | 0.86% | 0.91% | -41.38x | 14.43x | 9.61x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
